Clearmind Medicine (CMND) Exchange Rate Effect (2022 - 2026)
Clearmind Medicine (CMND) posted quarterly Exchange Rate Effect of -$1949.0 for Q2 2026, down 9845.0% year-over-year from $20.0 in Q2 2025, and down 178.68% quarter-over-quarter from $2477.0 in Q1 2026.
Clearmind Medicine (CMND) Exchange Rate Effect (2022 - 2026) Analysis & Trends
Clearmind Medicine's Exchange Rate Effect history runs 5 years deep, the most recent figure standing at -$1949.0 for Q2 2026.
- In Q2 2026, Exchange Rate Effect fell 9845.0% year-over-year to -$1949.0; the TTM figure through Apr 2026 stood at $5181.0 (up 189.19% YoY), while the FY2025 annual figure was $3217.0, up 127.86% from the prior year.
- Exchange Rate Effect for Q2 2026 stood at -$1949.0, down from $2477.0 in the prior quarter.
- The five-year high for Exchange Rate Effect was $355.0 million in Q3 2022, with the low at -$355.0 million in Q4 2022.
- The 5-year median for Exchange Rate Effect is -$861.0 (2025), against an average of -$4042.4.
- The sharpest annual moves came in 2025 and 2026: Exchange Rate Effect surged 291.59% in 2025, then slumped 9845.0% in 2026.
- Clearmind Medicine's Exchange Rate Effect stood at -$355.0 million in 2022, then jumped by 99.99% to -$37708.0 in 2023, then surged by 96.04% to -$1495.0 in 2024, then jumped by 42.41% to -$861.0 in 2025, then slumped by 126.36% to -$1949.0 in 2026.
- Business Quant data shows CMND's Exchange Rate Effect at -$1949.0 in Q2 2026, $2477.0 in Q1 2026, and -$861.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -2.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 19.84 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | -2.45 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -287,000.00 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 1.63 Mn |
| 10 | Clearmind Medicine | 520,887.91 | -13.07 Mn | - | -1,949.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -1,949.00 |
| Apr 30, 2026 | -1,949.00 |
| Jan 31, 2026 | 2,477.00 |
| Jan 31, 2026 | 2,477.00 |
| Oct 31, 2025 | -861.00 |
| Oct 31, 2025 | -861.00 |
| Jul 31, 2025 | 5,514.00 |
| Jul 31, 2025 | 5,514.00 |
| Apr 30, 2025 | 20.00 |
| Apr 30, 2025 | 20.00 |
| Jan 31, 2025 | -1,456.00 |
| Jan 31, 2025 | -1,456.00 |
| Oct 31, 2024 | -1,495.00 |
| Oct 31, 2024 | -1,495.00 |
| Jul 31, 2024 | -2,878.00 |
| Jul 31, 2024 | -2,878.00 |
| Apr 30, 2024 | -10,898.00 |
| Apr 30, 2024 | -10,898.00 |
| Jan 31, 2024 | 3,723.00 |
| Jan 31, 2024 | 3,723.00 |